Are We Ready With Prevention for Type 1 Diabetes? Article Swipe
Evelina Maines
,
Roberto Franceschi
,
Francesca Di Candia
,
Enza Mozzillo
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/dmrr.70101
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/dmrr.70101
Definitive prevention for type 1 diabetes (T1D) is not yet available, but we are now entering a new era where disease‐modifying therapies are becoming available in T1D to halt disease progression. In this review, we present up‐to‐date knowledge related to the prevention of T1D in youth, involving disease‐modifying therapies at different T1D stages. A narrative literature review utilising the PubMed/MEDLINE database was performed using the keywords ‘screening’, ‘prevention’, ‘Disease‐modifying therapy’, and ‘Diabetes Mellitus, Type 1’ [Mesh] in youth aged 0–18 years. Only teplizumab has been approved by the FDA as the first drug shown to delay the onset of Stage 3 T1D. Other monoclonal antibodies targeting specific immune cells, agents targeting specific cytokines, antigen‐specific therapies, and immunomodulant and/or immunosuppressive agents have been studied alone or in combination to control or delay the progression of beta‐cell destruction. In individuals with Stage 3 T1D, several intervention trials have led to a temporary improvement in beta‐cell function, but this benefit has consistently been short‐lived. Ongoing and future research will be essential to refine patient selection, identify additional therapeutic targets, and optimise the timing and durability of immunotherapy responses.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1002/dmrr.70101
- OA Status
- hybrid
- References
- 57
- OpenAlex ID
- https://openalex.org/W4415543963
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415543963Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/dmrr.70101Digital Object Identifier
- Title
-
Are We Ready With Prevention for Type 1 Diabetes?Work title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-01Full publication date if available
- Authors
-
Evelina Maines, Roberto Franceschi, Francesca Di Candia, Enza MozzilloList of authors in order
- Landing page
-
https://doi.org/10.1002/dmrr.70101Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1002/dmrr.70101Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
57Number of works referenced by this work
Full payload
| id | https://openalex.org/W4415543963 |
|---|---|
| doi | https://doi.org/10.1002/dmrr.70101 |
| ids.doi | https://doi.org/10.1002/dmrr.70101 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41137714 |
| ids.openalex | https://openalex.org/W4415543963 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000517 |
| mesh[1].descriptor_ui | D003922 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | prevention & control |
| mesh[1].descriptor_name | Diabetes Mellitus, Type 1 |
| mesh[2].qualifier_ui | Q000276 |
| mesh[2].descriptor_ui | D003922 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | immunology |
| mesh[2].descriptor_name | Diabetes Mellitus, Type 1 |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D002648 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Child |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D000293 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Adolescent |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D018450 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Disease Progression |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D007167 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Immunotherapy |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D006801 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Humans |
| mesh[8].qualifier_ui | Q000517 |
| mesh[8].descriptor_ui | D003922 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | prevention & control |
| mesh[8].descriptor_name | Diabetes Mellitus, Type 1 |
| mesh[9].qualifier_ui | Q000276 |
| mesh[9].descriptor_ui | D003922 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | immunology |
| mesh[9].descriptor_name | Diabetes Mellitus, Type 1 |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D002648 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Child |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000293 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Adolescent |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D018450 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Disease Progression |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D007167 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Immunotherapy |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D006801 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Humans |
| mesh[15].qualifier_ui | Q000517 |
| mesh[15].descriptor_ui | D003922 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | prevention & control |
| mesh[15].descriptor_name | Diabetes Mellitus, Type 1 |
| mesh[16].qualifier_ui | Q000276 |
| mesh[16].descriptor_ui | D003922 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | immunology |
| mesh[16].descriptor_name | Diabetes Mellitus, Type 1 |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D002648 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Child |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D000293 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Adolescent |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D018450 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Disease Progression |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D007167 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Immunotherapy |
| type | review |
| title | Are We Ready With Prevention for Type 1 Diabetes? |
| biblio.issue | 7 |
| biblio.volume | 41 |
| biblio.last_page | e70101 |
| biblio.first_page | e70101 |
| topics[0].id | https://openalex.org/T11171 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9994000196456909 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1311 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Diabetes and associated disorders |
| topics[1].id | https://openalex.org/T10560 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9955000281333923 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2712 |
| topics[1].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[1].display_name | Diabetes Management and Research |
| topics[2].id | https://openalex.org/T10839 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9905999898910522 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2746 |
| topics[2].subfield.display_name | Surgery |
| topics[2].display_name | Pancreatic function and diabetes |
| is_xpac | False |
| apc_list.value | 4330 |
| apc_list.currency | USD |
| apc_list.value_usd | 4330 |
| apc_paid.value | 4330 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4330 |
| language | en |
| locations[0].id | doi:10.1002/dmrr.70101 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S83251063 |
| locations[0].source.issn | 1520-7552, 1520-7560 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1520-7552 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Diabetes/Metabolism Research and Reviews |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Diabetes/Metabolism Research and Reviews |
| locations[0].landing_page_url | https://doi.org/10.1002/dmrr.70101 |
| locations[1].id | pmid:41137714 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Diabetes/metabolism research and reviews |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41137714 |
| locations[2].id | pmh:oai:europepmc.org:11360883 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12553304 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5055532217 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0445-2974 |
| authorships[0].author.display_name | Evelina Maines |
| authorships[0].countries | IT |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210088115 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pediatrics S. Chiara Hospital of Trento APSS Trento Italy |
| authorships[0].institutions[0].id | https://openalex.org/I4210088115 |
| authorships[0].institutions[0].ror | https://ror.org/007x5wz81 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210088115 |
| authorships[0].institutions[0].country_code | IT |
| authorships[0].institutions[0].display_name | Ospedale Santa Chiara |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Evelina Maines |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pediatrics S. Chiara Hospital of Trento APSS Trento Italy |
| authorships[1].author.id | https://openalex.org/A5055069822 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2230-7148 |
| authorships[1].author.display_name | Roberto Franceschi |
| authorships[1].countries | IT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I193223587 |
| authorships[1].affiliations[0].raw_affiliation_string | CISMed—Centro Interdipartimentale di Scienze Mediche University of Trento Trento Italy |
| authorships[1].institutions[0].id | https://openalex.org/I193223587 |
| authorships[1].institutions[0].ror | https://ror.org/05trd4x28 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I193223587 |
| authorships[1].institutions[0].country_code | IT |
| authorships[1].institutions[0].display_name | University of Trento |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Roberto Franceschi |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | CISMed—Centro Interdipartimentale di Scienze Mediche University of Trento Trento Italy |
| authorships[2].author.id | https://openalex.org/A5083747022 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-6746-1827 |
| authorships[2].author.display_name | Francesca Di Candia |
| authorships[2].countries | IT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I71267560 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Translational Medical Science University of Naples Federico II Naples Italy |
| authorships[2].institutions[0].id | https://openalex.org/I71267560 |
| authorships[2].institutions[0].ror | https://ror.org/05290cv24 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I71267560 |
| authorships[2].institutions[0].country_code | IT |
| authorships[2].institutions[0].display_name | University of Naples Federico II |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Francesca di Candia |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Translational Medical Science University of Naples Federico II Naples Italy |
| authorships[3].author.id | https://openalex.org/A5080239986 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8437-8494 |
| authorships[3].author.display_name | Enza Mozzillo |
| authorships[3].countries | IT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I71267560 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Translational Medical Science University of Naples Federico II Naples Italy |
| authorships[3].institutions[0].id | https://openalex.org/I71267560 |
| authorships[3].institutions[0].ror | https://ror.org/05290cv24 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I71267560 |
| authorships[3].institutions[0].country_code | IT |
| authorships[3].institutions[0].display_name | University of Naples Federico II |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Enza Mozzillo |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Translational Medical Science University of Naples Federico II Naples Italy |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1002/dmrr.70101 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-25T00:00:00 |
| display_name | Are We Ready With Prevention for Type 1 Diabetes? |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11171 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9994000196456909 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1311 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Diabetes and associated disorders |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1002/dmrr.70101 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S83251063 |
| best_oa_location.source.issn | 1520-7552, 1520-7560 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1520-7552 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Diabetes/Metabolism Research and Reviews |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Diabetes/Metabolism Research and Reviews |
| best_oa_location.landing_page_url | https://doi.org/10.1002/dmrr.70101 |
| primary_location.id | doi:10.1002/dmrr.70101 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S83251063 |
| primary_location.source.issn | 1520-7552, 1520-7560 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1520-7552 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Diabetes/Metabolism Research and Reviews |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Diabetes/Metabolism Research and Reviews |
| primary_location.landing_page_url | https://doi.org/10.1002/dmrr.70101 |
| publication_date | 2025-10-01 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2326904657, https://openalex.org/W1989179364, https://openalex.org/W4377043576, https://openalex.org/W4378529533, https://openalex.org/W4408133845, https://openalex.org/W4388669348, https://openalex.org/W4379791620, https://openalex.org/W4306407089, https://openalex.org/W4404595942, https://openalex.org/W2095256598, https://openalex.org/W4297982530, https://openalex.org/W3016988719, https://openalex.org/W4405363822, https://openalex.org/W4391973119, https://openalex.org/W4401035092, https://openalex.org/W4283775061, https://openalex.org/W2966243748, https://openalex.org/W2144243406, https://openalex.org/W4385784108, https://openalex.org/W2793637425, https://openalex.org/W4376618367, https://openalex.org/W2891482942, https://openalex.org/W2165571979, https://openalex.org/W2781860640, https://openalex.org/W1990514655, https://openalex.org/W614574849, https://openalex.org/W2776280, https://openalex.org/W2769332703, https://openalex.org/W2059593985, https://openalex.org/W2554850815, https://openalex.org/W2148774610, https://openalex.org/W4401541681, https://openalex.org/W2948104235, https://openalex.org/W3133678581, https://openalex.org/W4362575034, https://openalex.org/W2138212565, https://openalex.org/W4406217080, https://openalex.org/W2333217165, https://openalex.org/W2000512567, https://openalex.org/W2114603595, https://openalex.org/W2123726955, https://openalex.org/W2106218189, https://openalex.org/W2116929194, https://openalex.org/W3134454558, https://openalex.org/W3099245374, https://openalex.org/W3212575051, https://openalex.org/W4280495960, https://openalex.org/W2046620531, https://openalex.org/W3092645135, https://openalex.org/W4396720336, https://openalex.org/W4224223069, https://openalex.org/W2036559281, https://openalex.org/W4321749334, https://openalex.org/W4248517419, https://openalex.org/W4396624323, https://openalex.org/W4389376234, https://openalex.org/W1896586019 |
| referenced_works_count | 57 |
| abstract_inverted_index.1 | 5 |
| abstract_inverted_index.3 | 101, 141 |
| abstract_inverted_index.A | 54 |
| abstract_inverted_index.a | 17, 149 |
| abstract_inverted_index.In | 32, 137 |
| abstract_inverted_index.as | 90 |
| abstract_inverted_index.at | 50 |
| abstract_inverted_index.be | 167 |
| abstract_inverted_index.by | 87 |
| abstract_inverted_index.in | 26, 45, 77, 126, 152 |
| abstract_inverted_index.is | 8 |
| abstract_inverted_index.of | 43, 99, 134, 183 |
| abstract_inverted_index.or | 125, 130 |
| abstract_inverted_index.to | 28, 40, 95, 128, 148, 169 |
| abstract_inverted_index.we | 13, 35 |
| abstract_inverted_index.FDA | 89 |
| abstract_inverted_index.T1D | 27, 44, 52 |
| abstract_inverted_index.and | 71, 116, 163, 177, 181 |
| abstract_inverted_index.are | 14, 23 |
| abstract_inverted_index.but | 12, 155 |
| abstract_inverted_index.era | 19 |
| abstract_inverted_index.for | 3 |
| abstract_inverted_index.has | 84, 158 |
| abstract_inverted_index.led | 147 |
| abstract_inverted_index.new | 18 |
| abstract_inverted_index.not | 9 |
| abstract_inverted_index.now | 15 |
| abstract_inverted_index.the | 41, 59, 65, 88, 91, 97, 132, 179 |
| abstract_inverted_index.was | 62 |
| abstract_inverted_index.yet | 10 |
| abstract_inverted_index.1’ | 75 |
| abstract_inverted_index.Only | 82 |
| abstract_inverted_index.T1D, | 142 |
| abstract_inverted_index.T1D. | 102 |
| abstract_inverted_index.Type | 74 |
| abstract_inverted_index.aged | 79 |
| abstract_inverted_index.been | 85, 122, 160 |
| abstract_inverted_index.drug | 93 |
| abstract_inverted_index.halt | 29 |
| abstract_inverted_index.have | 121, 146 |
| abstract_inverted_index.this | 33, 156 |
| abstract_inverted_index.type | 4 |
| abstract_inverted_index.will | 166 |
| abstract_inverted_index.with | 139 |
| abstract_inverted_index.(T1D) | 7 |
| abstract_inverted_index.Other | 103 |
| abstract_inverted_index.Stage | 100, 140 |
| abstract_inverted_index.alone | 124 |
| abstract_inverted_index.delay | 96, 131 |
| abstract_inverted_index.first | 92 |
| abstract_inverted_index.onset | 98 |
| abstract_inverted_index.shown | 94 |
| abstract_inverted_index.using | 64 |
| abstract_inverted_index.where | 20 |
| abstract_inverted_index.youth | 78 |
| abstract_inverted_index.0–18 | 80 |
| abstract_inverted_index.[Mesh] | 76 |
| abstract_inverted_index.agents | 110, 120 |
| abstract_inverted_index.and/or | 118 |
| abstract_inverted_index.cells, | 109 |
| abstract_inverted_index.future | 164 |
| abstract_inverted_index.immune | 108 |
| abstract_inverted_index.refine | 170 |
| abstract_inverted_index.review | 57 |
| abstract_inverted_index.timing | 180 |
| abstract_inverted_index.trials | 145 |
| abstract_inverted_index.years. | 81 |
| abstract_inverted_index.youth, | 46 |
| abstract_inverted_index.Ongoing | 162 |
| abstract_inverted_index.benefit | 157 |
| abstract_inverted_index.control | 129 |
| abstract_inverted_index.disease | 30 |
| abstract_inverted_index.patient | 171 |
| abstract_inverted_index.present | 36 |
| abstract_inverted_index.related | 39 |
| abstract_inverted_index.review, | 34 |
| abstract_inverted_index.several | 143 |
| abstract_inverted_index.stages. | 53 |
| abstract_inverted_index.studied | 123 |
| abstract_inverted_index.ABSTRACT | 0 |
| abstract_inverted_index.approved | 86 |
| abstract_inverted_index.becoming | 24 |
| abstract_inverted_index.database | 61 |
| abstract_inverted_index.diabetes | 6 |
| abstract_inverted_index.entering | 16 |
| abstract_inverted_index.identify | 173 |
| abstract_inverted_index.keywords | 66 |
| abstract_inverted_index.optimise | 178 |
| abstract_inverted_index.research | 165 |
| abstract_inverted_index.specific | 107, 112 |
| abstract_inverted_index.targets, | 176 |
| abstract_inverted_index.Mellitus, | 73 |
| abstract_inverted_index.available | 25 |
| abstract_inverted_index.different | 51 |
| abstract_inverted_index.essential | 168 |
| abstract_inverted_index.function, | 154 |
| abstract_inverted_index.involving | 47 |
| abstract_inverted_index.knowledge | 38 |
| abstract_inverted_index.narrative | 55 |
| abstract_inverted_index.performed | 63 |
| abstract_inverted_index.targeting | 106, 111 |
| abstract_inverted_index.temporary | 150 |
| abstract_inverted_index.therapies | 22, 49 |
| abstract_inverted_index.utilising | 58 |
| abstract_inverted_index.Definitive | 1 |
| abstract_inverted_index.additional | 174 |
| abstract_inverted_index.antibodies | 105 |
| abstract_inverted_index.available, | 11 |
| abstract_inverted_index.cytokines, | 113 |
| abstract_inverted_index.durability | 182 |
| abstract_inverted_index.literature | 56 |
| abstract_inverted_index.monoclonal | 104 |
| abstract_inverted_index.prevention | 2, 42 |
| abstract_inverted_index.responses. | 185 |
| abstract_inverted_index.selection, | 172 |
| abstract_inverted_index.teplizumab | 83 |
| abstract_inverted_index.therapies, | 115 |
| abstract_inverted_index.beta‐cell | 135, 153 |
| abstract_inverted_index.combination | 127 |
| abstract_inverted_index.improvement | 151 |
| abstract_inverted_index.individuals | 138 |
| abstract_inverted_index.progression | 133 |
| abstract_inverted_index.therapeutic | 175 |
| abstract_inverted_index.therapy’, | 70 |
| abstract_inverted_index.‘Diabetes | 72 |
| abstract_inverted_index.consistently | 159 |
| abstract_inverted_index.destruction. | 136 |
| abstract_inverted_index.intervention | 144 |
| abstract_inverted_index.progression. | 31 |
| abstract_inverted_index.immunotherapy | 184 |
| abstract_inverted_index.PubMed/MEDLINE | 60 |
| abstract_inverted_index.immunomodulant | 117 |
| abstract_inverted_index.short‐lived. | 161 |
| abstract_inverted_index.up‐to‐date | 37 |
| abstract_inverted_index.‘screening’, | 67 |
| abstract_inverted_index.immunosuppressive | 119 |
| abstract_inverted_index.‘prevention’, | 68 |
| abstract_inverted_index.antigen‐specific | 114 |
| abstract_inverted_index.disease‐modifying | 21, 48 |
| abstract_inverted_index.‘Disease‐modifying | 69 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| citation_normalized_percentile.value | 0.53169014 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |